Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
A Phase 2 Basket Trial of Ulixertinib (BVD-523) in Combination With Hydroxychloroquine in Patients With Advanced GI Malignancies Harboring Mitogen-activated Protein Kinase (MAPK) Pathway Mutations (BVD-523-HCQ)
Sponsor: BioMed Valley Discoveries, Inc
Terminated
Lack of Enrollment for Remaining Open Baskets
Other terminated trials from BioMed Valley Discoveries, Inc
- Uveal Melanoma · Phase PHASE2 · Jul 2025
- Advanced Solid Tumor · Phase PHASE2 · May 2023
- Cancer of Pancreas · Phase PHASE1 · May 2020
- Diabetic Foot Infection · Phase PHASE2 · Feb 2014
- Prosthetic Joint Infections · Phase PHASE2 · Nov 2013
More terminations from BioMed Valley Discoveries, Inc
Other Gastrointestinal Cancer trials with similar outcome
This PHASE2 trial investigates Gastrointestinal Cancer and Tumor, Solid and is currently terminated or withdrawn. BioMed Valley Discoveries, Inc leads this study, which shows 16 recorded versions since 2022 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
16 versions recorded-
Oct 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2025 — Oct 2025 [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE2
▶ Show 11 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Jun 2023 — Mar 2024 [monthly]
Recruiting PHASE2
-
Feb 2023 — Jun 2023 [monthly]
Recruiting PHASE2
-
Jan 2023 — Feb 2023 [monthly]
Recruiting PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Recruiting PHASE2
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE2
-
Oct 2022 — Nov 2022 [monthly]
Recruiting PHASE2
-
Sep 2022 — Oct 2022 [monthly]
Recruiting PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Apr 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- BioMed Valley Discoveries, Inc
For direct contact, visit the study record on ClinicalTrials.gov .